Emergent BioSolutions (EBS) Net Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted Net Margin of 76.91% for Q2 2026, down 1865.54% on a QoQ basis from 4.36% in Q1 2026, and down 6839.0% year-over-year from 1.14% in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Net Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported Net Margin for 16 years, with the latest figure at 76.91% in Q2 2026.
- On a quarterly basis, Net Margin fell 6839.0% year-over-year to 76.91% in Q2 2026; TTM through Jun 2026 was 22.96%, a 3934.0% decrease from a year earlier, with the FY2025 full-year figure at 7.08%, up 2534.0% from the prior year.
- Net Margin was 76.91% for Q2 2026 at Emergent BioSolutions, down from 4.36% in the prior quarter.
- The five-year high for Net Margin was 39.07% in Q3 2024, with the low at 113.33% in Q1 2023.
- Average Net Margin over 5 years is 29.84%, with a median of 19.09% recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Net Margin tumbled 11212 bps in 2023, then soared 13645 bps in 2024.
- Over 5 years, Net Margin stood at 20.29% in 2022, then increased by 12 bps to 17.9% in 2023, then increased by 10 bps to 16.08% in 2024, then plunged by 128 bps to 36.72% in 2025, then slumped by 109 bps to 76.91% in 2026.
- The last three Net Margin figures came in at 76.91% (Q2 2026), 4.36% (Q1 2026), and 36.72% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 22.65% |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | -1.58% |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 25.56% |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 2.96% |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 13.90% |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | -76.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -76.91% |
| Mar 31, 2026 | 4.36% |
| Dec 31, 2025 | -36.72% |
| Sep 30, 2025 | 22.15% |
| Jun 30, 2025 | -8.52% |
| Mar 31, 2025 | 30.60% |
| Dec 31, 2024 | -16.08% |
| Sep 30, 2024 | 39.07% |
| Jun 30, 2024 | -111.15% |
| Mar 31, 2024 | 3.00% |
| Dec 31, 2023 | -17.90% |
| Sep 30, 2023 | -97.38% |
| Jun 30, 2023 | -77.36% |
| Mar 31, 2023 | -113.33% |
| Dec 31, 2022 | -20.29% |
| Sep 30, 2022 | -36.31% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -1.21% |
| Dec 31, 2021 | 24.27% |
| Sep 30, 2021 | -11.42% |
API Access
Emergent BioSolutions Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();